Funding for this research was provided by:
National Cancer Institute (R01CA097375, 5P30 CA016058-35)
International Breast Cancer Research Foundation
National Center for Advancing Translational Sciences (UL1TR001070)
Article History
Received: 10 July 2018
Accepted: 8 August 2019
First Online: 23 August 2019
Ethics approval and consent to participate
: Study approval was obtained at individual participating institutions in the Philippines, Vietnam, and Morocco and/or by supervising institutional review boards (IRBs) for these institutions and at the lead investigator’s American institutions (The Ohio State University or the University of Wisconsin). All participants provided written informed consent. All of the participating institutions and IRBs were registered with the Office for Human Subjects’ Protection (OHRP) in the USA.
: Not applicable.
: The authors declare that they have no competing interests.